Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

08/28 21:43   Ukrainian special services detain over 100 crime lords, including from Russia, Moldova, at crime boss funerals
 
08/28 21:21   Kyiv reports nearly 30 militia fire attacks involving tank weapons, heavy artillery on Sunday
 
08/28 20:42   Bokeria dismisses rumors about his trip to Tashkent to cure President Karimov
 
08/28 20:14   Ukrainian JCCC side accuses militia of mortar, portable rocket launcher fire on Krasnohorivka
 
08/28 18:40   Kyrgyzstan declares mourning for victims of fire in Moscow, road accident on Bishkek-Osh highway (Part 2)
 
08/28 17:03   DPR reports nearly 330 ceasefire breaches over past 24 hours, says Kyiv opens pinpoint fire on residential houses
 
08/28 16:24   Kyrgyzstan declares mourning over victims of fire in Moscow, road accident on Bishkek-Osh highway on Aug 29
 
08/28 16:14   Medvedev lifts ban on Russian charters to Turkey (Part 2)
 
08/28 15:52   Residents of Ukrainian village of Loshchynivka demand gypsies' eviction
 
08/28 15:37   Uzbekistan president hospitalized (Part 2)
 




 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

August 28, 2016
 
21:43
Ukrainian special services detain over 100 crime lords, including from Russia, Moldova, at crime boss funerals
 
21:21
Kyiv reports nearly 30 militia fire attacks involving tank weapons, heavy artillery on Sunday
 
20:42
Bokeria dismisses rumors about his trip to Tashkent to cure President Karimov
 
20:14
Ukrainian JCCC side accuses militia of mortar, portable rocket launcher fire on Krasnohorivka
 
18:40
 
17:03
DPR reports nearly 330 ceasefire breaches over past 24 hours, says Kyiv opens pinpoint fire on residential houses
 
16:24
Kyrgyzstan declares mourning over victims of fire in Moscow, road accident on Bishkek-Osh highway on Aug 29
 
16:14
Medvedev lifts ban on Russian charters to Turkey (Part 2)
 
15:52
Residents of Ukrainian village of Loshchynivka demand gypsies' eviction
 
15:37
Uzbekistan president hospitalized (Part 2)
 
15:30
Medvedev lifts ban on Russian charters to Turkey
 
15:19
Uzbekistan president hospitalized
 
15:14
Airline companies start filing applications to Rosaviatsia after lifting of Turkish charter restrictions - Russian Transport Ministry
 
15:04
AIRLINE COMPANIES BEGIN FILING APPLICATIONS TO ROSAVIATSIA AFTER LIFTING OF RESTRICTIONS ON CHARTER FLIGHTS TO TURKEY- TRANSPORT MINISTRY
 
 more headlines 



Interviews
 

.
NATO Secretary General Jens Stoltenberg has given an interview to Interfaxs correspondent Alexander Korzun ahead of the alliances summit in Warsaw due on July 8-9 in which he speaks about place of the Russian topic on the summits agenda and Russia-NATO relations in general.

more
.
.
Israeli Prime Minister Benjamin Netanyahu has given an interview to Interfax ahead of his visit to Russia in which he speaks about the influence that his personal relationship with Russian President Vladimir Putin have on the development of interstate ties, about Israels plans regarding new gas fields and said that Israel will into allow Syria to turn into a source of aggression. This will be Netanyahus third visit in under a year.

more
.
.
Indonesian Ambassador to Russia Wahid Supriyadi has given an interview with Interfax in which he speaks about the results of the Russia-ASEAN summit, prospects for achieving an agreement on oil production freeze in OPEC, Indonesian-Russian military and technological cooperation and the launch of direct air communication between Indonesia and Russia.

more

 
  
 ©   1991—2016   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100